Synthesis and antitumor activity of duocarmycin derivatives: A-Ring pyrrole analogues of duocarmycin B2

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 8, 1996, Pages 1379-1391

  Nagamura, Satoru ^a   Kobayashi, Eiji ^a   Gomi, Katsushige ^a   Saito, Hiromitsu ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DU 86; DUOCARMYCIN A; DUOCARMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS; SARCOMA 180; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE;

EID: 0030221405     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00132-0     Document Type: Article

References (44)

1. 1. (a) Takahashi, I.; Takahashi, K.; Ichimura, M.; Morimoto, M.; Asano, K.; Kawamoto, I.; Tomita, F.; Nakano, H. J. Antibiot. 1988, 41, 1915;
2. (b) Yasuzawa, T.; Iida, T.; Muroi, K.; Ichimura, M.; Takahashi, K.; Sano, H. Chem. Pharm. Bull. 1988, 36, 3728;
3. (c) Ichimura, M.; Muroi, K.; Asano, K.; Kawamoto, I.; Tomita, F.; Morimoto, M.; Nakano, H. J. Antibiot. 1988, 41, 1285;
4. (d) Ogawa, T.; Ichimura, M.; Katsumata, S.; Morimoto, M.; Takahashi, K. J. Antibiot. 1989, 42, 1299;
5. (e) Ichimura, M.; Ogawa, T.; Takahashi, K.; Kobayashi, E.; Kawamoto, I.; Yasuzawa, T.; Takahashi, I.; Nakano, H. J. Antibiot. 1990, 43, 1037;
6. (f) Ichimura, M.; Ogawa, T.; Katsumata, S.; Takahashi, K.; Takahashi, I.; Nakano, H. J. Antibiot. 1991, 44, 1045;
7. (g) Yasuzawa, T.; Saitoh, Y.; Ichimura, M.; Takahashi, I.; Sano, H. J. Antibiot. 1991, 44, 445;
8. (h) Yasuzawa, T.; Muroi, K.; Ichimura, M.; Takahashi, I.; Ogawa, T.; Takahashi, K.; Sano, H.; Saitoh, Y. Chem. Pharm. Bull. 1995, 43, 378.
9. 2. (a) Sugiyama, H.; Hosoda, M.; Saito, I.; Asai, A.; Saito, H. Tetrahedron Lett. 1990, 31, 7197;
10. (b) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Org. Chem. 1990, 55, 4499;
11. (c) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H.; Munk, S. A.; Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961;
12. (d) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Am. Chem. Soc. 1991, 113, 6645;
13. (e) Sugiyama, H.; Ohmori, K.; Chan, K. L.; Hosoda, M.; Asai, A.; Saito, H.; Saito, I. Tetrahedron Lett. 1993, 34, 2179.
14. 3. (a) Hanka, L. J.; Dietz, A.; Gerpheide, S. A.; Kuentzel, S. L.; Martin, D. G. J. Antibiot. 1978, 31, 1211;
15. (b) Martin, D. G.; Chidester, C. G.; Duchamp, D. J.; Mizsak S. A. J. Antibiot. 1980, 33, 902;
16. (c) Reynolds, V. L.; McGovren, J. P.; Hurley, L. H. J. Antibiot. 1986, 39, 319.
17. 4. Its analogues are promising candidates in the clinical development, (a) Li, L. H.; Kelly, R. C.; Warpehoski, M. A.; McGovren, J. P.; Gebhard, I.; Dekoning, T. F. Invest. New Drugs 1991, 9, 137;
18. (b) Li, L. H.; Dekoning, T. F.; Kelly, R. C.; Krueger, W. C.; McGovren, J. P.; Pudbury, G. E.; Petzold, G. L.; Wallace, T. L.; Ouding, R. J.; Prairie, M. D.; Gebhard, I. Cancer Res. 1992, 52, 4904.
19. 5. Gomi, K.; Kobayashi, E.; Miyoshi, K.; Ashizawa, T.; Okamoto, A.; Ogawa, T.; Katsumata, S.; Mihara, A.; Okabe, M.; Hirata, T. Jpn. J. Cancer Res. 1992, 83, 113.
20. 6. Nagamura, S.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1995, 43, 1530.
21. 7. (a) Nagamura, S.; Asai, A.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, 44, printed,
22. (b) Kobayashi, E.; Okamoto, A.; Asada, M.; Okabe, M.; Nagamura, S.; Asai, A.; Saito, H.; Gomi, K.; Hirata, T. Cancer Res. 1994, 54, 2404.
23. 8. Asai, A.; Nagamura, S.; Saito, H. J. Am. Chem. Soc. 1994, 116, 4171.
24. 9. Nagamura, S.; Kanda, Y.; Asai, A.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, 44, 933.
25. 10. (a) Berner, D.; Cox, D. P.; Dann, H. J. Am. Chem. Soc. 1982, 104, 2631;
26. (b) Abe, Y.; Suehiro, T. Chem. Lett. 1982, 337.
27. 4 under the same conditions, a 1:1 mixture of two 9-hydroxy compounds which had a five-and six-membered ring C was obtained. Unpublished data.
28. 3 cells was > 1000 nM at 72 h exposure, and compound 3 did not exhibit other biological activities.
29. 13. (a) Cacchi, S.; Ciattini, P. G.; Moreera, E.; Orter, G. Tetrahedron Lett. 1986, 27, 5541;
30. (b) Mitchell, T. N. Synthesis 1992, 803;
31. (c) Scott, W. J.; Stille, J. K. J. Am. Chem. Soc. 1986, 108, 3033.
32. 14. Mc Murry, J. E.; Scott, W. J. Tetrahedron Lett. 1983, 24, 979.
33. 15. Zitko, B. A.; Howes, J. F.; Razdan, R. K.; Dalzell, B. C.; Dalzell, H. C.; Sheehan, J. C.; Pars, H. G. Science 1972, 177, 442.
34. 16. (a) Hansen, J.; Mork, N.; Bundgaard, H. Int. J. Pharm. 1992, 81, 253;
35. (b) Heymann, E. Metabolic Basis of Detoxification; Jakoby, W. B.; Bend, J. R.; Caldwell, J., Eds; Academic: New York, 1982;
36. (c) Ohe, Y.; Sasaki, Y.; Shinkai, T.; Eguchi, K.; Tamura, T.; Kojima, A.; Kunikane, H.; Okamoto, H.; Karato, A.; Ohmatsu, H.; Kanzawa, F.; Saijo, N. J. Natl. Cancer Inst. 1992, 84, 972;
37. (d) Tsuji, T.; Kaneda, D.; Kado, K.; Yokokura, T.; Yoshimoto, T.; Tsuru, D. Phamacobio-Dyn. 1991, 14, 341.
38. 17. (a) Asai, A.; Nagamura, S.; Saito, H.; Takahashi, I.; Nakano, H. Nucl. Acids Res. 1994, 22, 83;
39. (b) McGovren, J. P.; Clarke, G. L.; Pratt, E. A.; Dekoning, T. F. J. Antibiot. 1984, 37, 63.
40. 18. (a) Ogasawara, H.; Nishio, K.; Takeda, Y.; Ohmori, T.; Kubota, N.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1994, 85, 418;
41. (b) Okamoto, A.; Asai, A.; Saito, H.; Okabe, M.; Gomi, K. Jpn. J. Cancer Res. 1994, 85, 1304;
42. (c) Ogasawara, H.; Nishio, K.; Kanzawa, F.; Lee, Y.-S.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1995, 86, 124.
43. 19. Geran, R. I.; Greenberg, N. H.; MacDonald, M. M.; Schumacher, A. M.; Abbott, B. J. Cancer Chemother. Rep. 1972, 3, 1.
44. 20. Inaba, M.; Kobayashi, T.; Tashiro, T.; Sakurai, Y.; Maruo, K.; Ohnishi, Y.; Ueyama, Y.; Nomura, T. Cancer 1989, 64, 1577.